Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2200069	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2022-03-07		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSB2200038	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2022-03-07		Novo Nordisk A/S			view
JYSB2200039	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2022-03-07		Novo Nordisk A/S			view
CYSB2200068	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2022-03-07		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
CYSB2101231	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2021-10-19		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
CYSB2101230	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2021-10-19		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSB2101107	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2021-08-13		Novo Nordisk A/S			view
JYSB2101106	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2021-08-13		Novo Nordisk A/S			view
CYSB2000154	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2020-06-19	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2021-07-22	view
JYSB2000196	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2020-05-18	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-05-25	view
JYSB2000197	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2020-05-18	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-05-25	view
JYSF1900016	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2019-09-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-10-22	view
JYSF1900015	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2019-09-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-10-22	view
CXSL1900092	地特胰岛素注射液	insulin detemir	Injection	Biological Products(15)	New Drug Application	2019-08-28	华润昂德生物药业有限公司	Shandong E Hua Biology Medicine Co Ltd	In Review	2019-08-27	view
CYSB1900292	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2019-08-15	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	In Review	2019-08-14	view
JYSF1900007	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2019-07-04	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-07-24	view
JYSF1900006	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Supplementary Application	2019-07-04	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-07-24	view
JTS1900027	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Disposable Import Drug Application	2019-06-21	Novo Nordisk A/S	Novo Nordisk A/S	Certificate Issued	2019-07-05	view
JTS1900026	地特胰岛素注射液	insulin detemir	Injection	Biological Products	Disposable Import Drug Application	2019-06-21	Novo Nordisk A/S	Novo Nordisk A/S	Certificate Issued	2019-07-05	view
JYSZ1800048	地特胰岛素注射液	insulin detemir	Injection	Biological Products	License Renew	2018-09-30	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-09-16	view